[09.08.2026]
Building the AI network for medicine
Announcing our $150M Series C at a $3B valuation to bring Forus to every doctor's office in America.
Stories
[08.24.2026]
Lessons on Building the AI Infrastructure for Medication Access
Sahir Jaggi, founder and CEO of Forus, joins Pear Healthcare Playbook hosts Anson Zhou and Andrew Parambath to discuss medication access, AI infrastructure, and building a durable healthcare company.
- Rheumatology
[08.20.2026]
Helping patients move again: How Virginia Rheumatology Clinic accelerates biologic access
For patients living with rheumatic disease, faster access to treatment can mean moving with less pain, returning to daily routines, and getting pieces of their lives back. With Forus, Dr. Brinda Dixit and the Virginia Rheumatology Clinic team help patients start specialty medications faster while keeping them informed every step of the way.
[08.03.2026]
Accelerating Access to Medicine with Forus
General Catalyst's Chris Bischoff sits down with Forus’ founder and CEO Sahir Jaggi to unpack why one in three patients never get their first dose of prescription medication, how LLMs cut through the complexity stalling the drug supply chain, and how a network built at scale can make scientific progress the only limit on the medicine that people have access to.
- Neurology
[07.10.2026]
How Modern Migraine MD enables providers to prescribe on clinical judgement with Forus
Modern Migraine used to leave prior authorizations incomplete because of limited internal capacity. With Forus, the neurology practice can confidently prescribe the therapies their providers choose and help more patients access the care they recommend.
[07.09.2026]
Forus and American Gastroenterological Association announce strategic partnership to improve medication access for GI patients
Pairing AGA's clinical leadership with Forus' medication access platform, the strategic partnership aims to help GI patients get faster access to the therapies their physicians prescribe
[07.01.2026]
How Forus supports the Medicare GLP-1 Bridge Program
What providers should know about the Medicare GLP-1 Bridge Program, including patient eligibility, prescribing requirements, and how Forus developed a provider-informed workflow to support prior authorization and pharmacy processing for this new program. Community contributor: Jeffrey H. Schneider, MD, DABOM, dual board-certified in gastroenterology and obesity medicine.
[06.07.2026]
Building the AI Infrastructure for Medication Access with Sahir Jaggi
In this Becker's Healthcare Podcast episode, Sahir Jaggi (CEO) discusses how Forus is using AI to automate prior authorizations, appeals, and medication access workflows, helping providers and patients navigate one of healthcare’s most complex challenges.
- Allergy
[06.04.2026]
From weeks to hours: How Aspire Allergy & Sinus automated prior authorizations across 63 offices
Forus partnered with Aspire Allergy & Sinus to cut prior authorization turnaround times from two to four weeks to under two days — submitting PAs in under 24 hours, averaging approvals in just 1.7 days, and serving 1,500+ patients across 63 offices in the first few months.
[05.12.2026]
Building the foundation for modern medicine
Announcing $160M in funding to build the AI-powered network to help doctors, pharmacies, payers, and biopharma bring new science to patients.
- Allergy
[05.11.2026]
Faster approvals & stronger appeals: Family Allergy & Asthma’s prior authorization transformation
Forus helped one of the country's largest independent allergy practices cut PA turnaround time from 7+ days to 1.1, reduce per-patient workload by 70%, and drive a meaningful lift in first-attempt appeal approvals with data-rich, high-quality letters.
[04.02.2026]
OpenEvidence and Forus partner to streamline evidence-based prescribing and prior authorizations
OpenEvidence powers the clinical decision backed by evidence and Forus automates every step from prescription to patient.